Review article · 2019
Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review
Journal of Clinical Pharmacy and Therapeutics, 45(1), 1–15 · Published 22 August 2019 · DOI 10.1111/jcpt.13034
In brief
“Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review” is a 2019 review article by Iara Carolina Barbosa Henrique and 3 co-authors, published in Journal of Clinical Pharmacy and Therapeutics. OpenAlex counts 6 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 6
- Most cited in
- 2021 (3)
- Field-weighted impact
- 0.28
- References
- 53
- Authors
- 4
Abstract
WHAT IS KNOWN AND OBJECTIVES: Schizophrenia is a serious mental disorder and is associated with substantial economic and social burden. Cost-effectiveness analysis is important to assess the costs of different therapeutic options. However, there is a lack of information on the reporting quality of economic evaluations, cost drivers, as well as updated data focused on… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Henrique, I. C. B., Lima, T. D. M., de Melo, D. O., & Aguiar, P. M. (2019). Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review. Journal of Clinical Pharmacy and Therapeutics, 45(1), 1–15. https://doi.org/10.1111/jcpt.13034
MLA 9
Henrique, Iara Carolina Barbosa, et al. “Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review.” Journal of Clinical Pharmacy and Therapeutics, vol. 45, no. 1, 2019, pp. 1–15. https://doi.org/10.1111/jcpt.13034.
Chicago
Henrique, Iara Carolina Barbosa, Tácio de Mendonça Lima, Daniela Oliveira de Melo, and Patrícia Melo Aguiar. 2019. “Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review.” Journal of Clinical Pharmacy and Therapeutics 45 (1): 1–15. https://doi.org/10.1111/jcpt.13034.
Harvard
Henrique, I. C. B. et al. (2019) ‘Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review’, Journal of Clinical Pharmacy and Therapeutics, 45(1), pp. 1–15. doi:10.1111/jcpt.13034.
IEEE
I. C. B. Henrique, T. D. M. Lima, D. O. de Melo, and P. M. Aguiar, “Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review,” Journal of Clinical Pharmacy and Therapeutics, vol. 45, no. 1, pp. 1–15, 2019, doi: 10.1111/jcpt.13034.
BibTeX
@article{henrique2019economic,
title = {{Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review}},
author = {Henrique, Iara Carolina Barbosa and Lima, Tácio de Mendonça and de Melo, Daniela Oliveira and Aguiar, Patrícia Melo},
journal = {Journal of Clinical Pharmacy and Therapeutics},
year = {2019},
volume = {45},
number = {1},
pages = {1--15},
doi = {10.1111/jcpt.13034},
url = {https://doi.org/10.1111/jcpt.13034}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 1 | |
| 2021 | 3 | |
| 2022 | 1 | |
| 2024 | 1 |
Its field-weighted citation impact is 0.28: it has been cited 0.28 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- aripiprazole
- schizophrenia
- cost-effectiveness
- economic evaluation
- reporting quality
- CHEERS
- relapse rate
- antipsychotic drugs
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Henrique, I. C. B., Lima, T. D. M., de Melo, D. O., & Aguiar, P. M. (2019). Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review. Journal of Clinical Pharmacy and Therapeutics, 45(1), 1–15. https://doi.org/10.1111/jcpt.13034
How many times has this paper been cited?
6 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Iara Carolina Barbosa Henrique, Tácio de Mendonça Lima, Daniela Oliveira de Melo, Patrícia Melo Aguiar.
What is the DOI of this paper?
10.1111/jcpt.13034, permanently at https://doi.org/10.1111/jcpt.13034. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.